CL2013001316A1 - Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior. - Google Patents

Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.

Info

Publication number
CL2013001316A1
CL2013001316A1 CL2013001316A CL2013001316A CL2013001316A1 CL 2013001316 A1 CL2013001316 A1 CL 2013001316A1 CL 2013001316 A CL2013001316 A CL 2013001316A CL 2013001316 A CL2013001316 A CL 2013001316A CL 2013001316 A1 CL2013001316 A1 CL 2013001316A1
Authority
CL
Chile
Prior art keywords
organisms
composition
respiratory tract
protect against
upper respiratory
Prior art date
Application number
CL2013001316A
Other languages
English (en)
Inventor
Annick Mercenier
Guenolee Prioult
Sophie Nutten
Valerie Petit
Clara Lucia Garcia-Rodenas
Monique Julita
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43645899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013001316(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2013001316A1 publication Critical patent/CL2013001316A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL2013001316A 2010-11-11 2013-05-10 Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior. CL2013001316A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10190819A EP2455092A1 (en) 2010-11-11 2010-11-11 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

Publications (1)

Publication Number Publication Date
CL2013001316A1 true CL2013001316A1 (es) 2013-10-18

Family

ID=43645899

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013001316A CL2013001316A1 (es) 2010-11-11 2013-05-10 Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.

Country Status (12)

Country Link
US (2) US9370538B2 (es)
EP (2) EP2455092A1 (es)
CN (1) CN103547276A (es)
AU (1) AU2011328136A1 (es)
BR (1) BR112013011881A2 (es)
CA (1) CA2817689A1 (es)
CL (1) CL2013001316A1 (es)
IL (1) IL226212A0 (es)
MX (1) MX2013005371A (es)
RU (1) RU2589706C2 (es)
SG (2) SG190215A1 (es)
WO (1) WO2012062780A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3068404B1 (en) 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
CN103798392B (zh) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
WO2015140299A1 (en) 2014-03-20 2015-09-24 Universiteit Antwerpen Oronasopharyngeal probiotics
BR112017013274A2 (pt) 2014-12-23 2018-02-06 4D Pharma Research Limited polipeptídeo e imunomodulação
SG11201704811YA (en) 2014-12-23 2017-07-28 4D Pharma Res Ltd Immune modulation
SI3307288T1 (sl) 2015-06-15 2019-11-29 4D Pharma Res Ltd Spojine, ki vsebujejo bakterijske seve
CN115364122A (zh) 2015-06-15 2022-11-22 4D制药研究有限公司 包含细菌菌株的组合物
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017037089A1 (en) * 2015-08-31 2017-03-09 Nestec S.A. Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN112569262A (zh) 2015-11-20 2021-03-30 4D制药研究有限公司 包含细菌菌株的组合物
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108883139B (zh) 2016-03-04 2022-04-26 4D制药有限公司 包含细菌菌株的组合物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
CN106176820A (zh) * 2016-07-12 2016-12-07 成都圣凯生物科技有限公司 一种改善上呼吸道微生态平衡的益生菌制剂及其制备方法
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US11590179B2 (en) 2017-02-28 2023-02-28 Precisionbiotics Group Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
DK3532603T3 (da) 2017-02-28 2020-12-07 Prec Group Limited Bifidobacterium longum til fordelagtig modulation af immunrespons på respiratorisk virusinfektion
MA48939B1 (fr) 2017-05-22 2021-06-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
JP6837581B2 (ja) 2017-06-14 2021-03-03 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ Ｍｅｇａｓｐｈａｅｒａ属の細菌株を含む組成物及びその使用
RS61210B1 (sr) 2017-06-14 2021-01-29 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
CN107213338A (zh) * 2017-07-19 2017-09-29 颐和益生（北京）科技有限公司 一种具有预防呼吸道感染的抗雾霾组合物、制备方法及应用
CN108004189B (zh) * 2018-01-18 2021-07-27 北京科拓恒通生物技术股份有限公司 一种复合益生乳酸菌粉剂及其制备方法与应用
JP7013419B2 (ja) * 2019-08-07 2022-02-15 日清食品ホールディングス株式会社 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用
CN113249244B (zh) * 2021-03-25 2022-10-14 上海理工大学 一种拮抗咽炎致病菌乙型溶血性链球菌的副干酪乳杆菌
EP4366750A1 (en) * 2021-07-09 2024-05-15 Claudio De Simone SPECIES, STRAINS AND COMPOSITIONS OF LACTIC ACID BACTERIA CAPABLE OF MODULATING BODY OXYGENATION BY INCREASING HIF-1alpha LEVELS

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0577904T3 (da) 1992-07-06 1997-10-27 Nestle Sa Mælkesyrebakterie.
EP1220688A1 (en) * 1999-10-15 2002-07-10 The van Kampen Group, Inc. Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
FR2809312B1 (fr) * 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
RU2258524C2 (ru) * 2003-10-23 2005-08-20 Закрытое акционерное общество "Партнер" Композиция для лечения острых респираторных заболеваний hib-этиологии у детей и способ лечения
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
WO2006124630A2 (en) * 2005-05-13 2006-11-23 New England Medical Center Hospitals, Inc. Compositions and methods for enhancing the efficacy of vaccines
MY148872A (en) * 2006-02-15 2013-06-14 Nestec Sa Use of bifidobacterium longum for the prevention and treatment of inflammation
EP2839836B1 (en) 2006-10-02 2017-08-30 DuPont Nutrition Biosciences ApS Probiotics for use in reducing symptoms of respiratory disease
WO2008053444A2 (en) * 2006-11-01 2008-05-08 The Procter & Gamble Company Treating a respiratory condition with bifidobacterium
EP2114423B2 (en) * 2007-02-28 2020-01-01 MJN U.S. Holdings LLC Inactivated lactobacillus rhammosus gg for treating systemic inflammation in infants
CA2707656C (en) * 2007-12-06 2018-05-22 Arla Foods Amba Probiotic bacteria and regulation of fat storage
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
CA2761573A1 (en) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children

Also Published As

Publication number Publication date
US20160250265A1 (en) 2016-09-01
CN103547276A (zh) 2014-01-29
RU2589706C2 (ru) 2016-07-10
RU2013126599A (ru) 2014-12-20
SG10201508826YA (en) 2015-11-27
US9370538B2 (en) 2016-06-21
US20130224253A1 (en) 2013-08-29
BR112013011881A2 (pt) 2016-11-01
EP2455092A1 (en) 2012-05-23
EP2637678A1 (en) 2013-09-18
CA2817689A1 (en) 2012-05-18
MX2013005371A (es) 2013-06-28
WO2012062780A1 (en) 2012-05-18
SG190215A1 (en) 2013-06-28
IL226212A0 (en) 2013-07-31
AU2011328136A1 (en) 2013-05-30

Similar Documents

Publication Publication Date Title
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
BR112013016535A2 (pt) extratos vegetais para o tratamento e prevenção de infecções
IT1398553B1 (it) Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
HK1207002A1 (en) Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections
EP2552203A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF VIRUS INFECTIONS
DK3251678T3 (da) Benzoxaborolderivater til behandling af bakterieinfektioner
EP2536406A4 (en) BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, COMPRISING THE TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
BRPI1010574A2 (pt) cereal infantil compreendendo micro-organismos probióticos não replicantes.
CL2013001134A1 (es) Composicion de yogurt congelado que comprende microorganismos probioticos no replicantes .
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
CL2013001315A1 (es) Composicion que comprende micro-organismo probioticos no replicantes extruidos.
SI2575971T1 (sl) Kombinirani rastlinski izvlečki za uporabo pri zdravljenju okužb z mikrobi
IL245412A0 (en) Polylinosinic-polycytidylic acid formulations for the treatment of upper respiratory tract infections
HK1202539A1 (en) (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel (r)-(r)(s)-
IT1401218B1 (it) Composizione ad attivita' bio-rigenerativa, riparativa ed eutrofizzante.
CL2013001313A1 (es) Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales
ITMI20110150U1 (it) "corpo del getto"
IT1400116B1 (it) Composizione fotoattiva ad elevata mobilita' delle lacune elettroniche.
WO2015044434A3 (de) FLUOR-9-METHYL-ß-CARBOLINE
WO2012084419A3 (de) Wirkstoffkombinationen aus glucosylglyceriden und einer oder mehreren gegen kopfschuppen wirksamen substanzen
DK2722053T3 (da) Antibakterielt middel til behandling af infektionssygdomme af bakteriel oprindelse
IT1395097B1 (it) Apparecchiatura per la manipolazione di lastre di grandi dimensioni.
WO2011139254A3 (en) Pharmaceutical formulations compising cefuroxime axetil
BR112012025829A2 (pt) ''composição de tratamento, composição líquido e utilização''
HK1211298A1 (en) Anti-poly-n-acetyl glucosamine (pnag) monoclonal antibody and uses thereof for the prevention or treatment of pnag expressing bacterial infection n-(pnag) pnag